Development of lung tissue models and their applications

Area of Science:

• Biomedical Engineering
• Toxicology
• Regenerative Medicine

Background:

• Lung health is vital, but animal testing for lung diseases, drug effects, and environmental impacts faces ethical and practical limitations.
• Developing human-relevant lung tissue models is essential to overcome species differences and ethical concerns associated with animal studies.
• Current regulatory acceptance for in vitro lung models in inhalation toxicology remains a significant hurdle.

Purpose of the Study:

• To review the challenges and advancements in creating human lung tissue models as alternatives to animal testing.
• To explore various in vitro lung model systems, including 2D and 3D cultures and lung-on-a-chip technologies.
• To highlight the potential applications of these models in disease modeling, infection studies, and environmental toxicology.

Main Methods:

• Discusses challenges in developing lung models from human cell sources (cell lines, primary cells, stem cells).
• Reviews 2D air-liquid interface and 3D culture techniques (organoids, bioprinting).
• Examines lung-on-a-chip models designed to replicate the lung microenvironment and function.

Main Results:

• Identifies key challenges in developing physiologically relevant human lung tissue models.
• Presents diverse in vitro approaches, from basic cultures to advanced organoids and microfluidic devices.
• Highlights the potential of these models for studying respiratory infections, diseases, and toxicological responses.

Conclusions:

• The development of accurate human lung tissue models is critical for advancing inhalation toxicology and disease research.
• Advanced models like organoids and lung-on-a-chip systems show promise for mimicking lung physiology and pathology.
• Successful implementation of these in vitro models will standardize future toxicological assessments and reduce reliance on animal testing.